Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
about
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationCCL21 Chemokine Therapy for Lung Cancer.Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of miceLow CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma.CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.CCL21 Cancer Immunotherapy.Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunityTargeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm.Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.Biomimetic delivery with micro- and nanoparticlesIntratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.Genetically engineered nanocarriers for drug delivery.Smart vaults: thermally-responsive protein nanocapsules.A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant.Chemokine-based immunotherapy: delivery systems and combination therapies.Nanoscale assemblies and their biomedical applications.Developments in the use of nanocapsules in oncology.Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity.Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.Protein nanoparticles for therapeutic protein delivery.Loco-regional administration of nanomedicines for the treatment of lung cancer.Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release.CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model.Stem cell-based therapies for HIV/AIDS.Protein based therapeutic delivery agents: Contemporary developments and challenges.Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake.Production of Recombinant Chemokines and Validation of Refolding.Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived CancersHome sweet home: the tumor microenvironment as a haven for regulatory T cells.Modulation of the Vault Protein-Protein Interaction for Tuning of Molecular Release.
P2860
Q26796395-D05A781D-5B3A-4C96-8A37-27B767C810D7Q28248811-B8B17172-3BAD-4569-A741-F1FECABD1CF2Q28727249-FBE25C1A-A3BB-4982-B138-F7DE725B4474Q33648983-4B14BD31-FDC5-4713-BCC1-CCA0E4536543Q33726546-9791CCE7-C4C8-4581-8763-C09C0F62DFCBQ33820300-60BEC0E9-3F0B-407E-870E-D3DAED543632Q34984596-11354B93-1485-4EB0-AB72-5D9AEE8D4E00Q35185966-9520BF18-DFBA-4558-97B8-0C9A5B6D3C54Q35580479-412D6CD4-33E8-48DF-8243-08697844565FQ35713347-A26A7D02-00C6-4F91-BFEA-CCD3E7CCF755Q36768786-E18D4706-8FE3-4AAB-BF33-36A8CEA331F2Q37033793-7D295892-3DB2-47AF-A4BB-7480DD1D98DBQ37676078-A219FA25-4F75-402C-9F09-232481EAD881Q37710407-0CC84EC2-2765-4EBC-BB18-6D2C56324735Q37727719-8370F991-D52F-4BC4-9346-0F002B801D5AQ38040509-C4792220-AF7E-4636-B8AE-6305B0AAE60CQ38072847-133B68D2-F08E-4298-A769-95858DD48C43Q38117157-BB4B3580-8C8D-438E-999E-5325BA9F44FBQ38172131-435D49C1-A6A6-4511-A61A-8EC3ECC933BEQ38526550-DE40905C-0F2E-4BFD-8BB3-843201C7DBF8Q38556744-D178210D-46B0-4CF8-80EB-A8968A3A932BQ38639228-9E7D4704-4A2D-4A26-B6F6-E0E99CD8D3C2Q38641476-BB2A9636-52D9-4707-BFA1-7FE503B83839Q38779935-20C29E65-A6FF-40FB-A355-8C5AF43A7DF5Q38827119-810FDCF3-4681-4CB5-9FD8-4FFDF0A4DAD6Q39273739-D07C14B6-FEF3-435E-B252-665E6971D892Q39316251-400F92BC-A62B-4403-A93A-0DBB31D908DCQ39614761-0288B07D-984C-46A4-A9DB-DCF93FD0A26EQ41457800-57B1BF18-B8F6-4F44-929A-97C9FEE38BF1Q43090164-B4E149C0-ECCD-445C-A0F8-21518D33B7D9Q47162074-A9E2ACE1-7BD2-48DF-AAC5-FF56314D2F6F
P2860
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@ast
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@en
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@en-gb
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@nl
type
label
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@ast
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@en
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@en-gb
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@nl
altLabel
Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth
@en
prefLabel
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@ast
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@en
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@en-gb
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@nl
P2093
P2860
P1433
P1476
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth
@en
P2093
Asa Andersson
Felicita Baratelli
Minu K Srivastava
Sherven Sharma
Steven M Dubinett
Upendra K Kar
P2860
P304
P356
10.1371/JOURNAL.PONE.0018758
P407
P577
2011-01-01T00:00:00Z